Eyes Down For Reckitt Benckiser Group Plc’s Results

We’ll see how Reckitt Benckiser Group Plc (LON: RB) fared in 2013.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Reckitt Benckiser Group (LSE: RB) (NASDAQOTH: RBGLY.US) shares have had a mixed ride — they’re up around 11% over 12 months to 4,656p, against a 3% rise for the FTSE 100, but it’s been a bit volatile.

The company was seen as something of a safe haven back in recession time, and its earnings were going strong — in 2009, we saw a 24% rise in earnings per share (EPS). But that growth has been slowing, down to just 7% by 2012. And analysts are actually expecting a modest fall of 1% for the year just ended in December 2013, with the same penciled in for 2014.

Results next week

Whether they’re right is something we shall find out on Wednesday 12 February, when we’ll have those 2013 results. But how has the year been going so far?

In third-quarter results released in October 2013, the owner of an array worldwide consumer brands reported like-for-like revenue growth of 5% for the quarter and the same for the year-to-date, excluding its pharmaceuticals business (RBP). Chief executive Rakesh Kapoor told us that the firm’s focus on health and hygiene and emerging markets was “delivering good results“.

And of RBP, he said “…we are commencing a strategic review of the business and will consider all options for maximising value for our shareholders. We expect the review to take some time and will update shareholders during the course of 2014“.

Prospects?

What of the full-year? Well, Mr Kapoor used that nasty “challenging” word when describing market conditions, but predicted full-year revenue growth of at least 6% with margins expected to be maintained.

Looking back further, statutory first-half EPS reported in July 2013 dropped 14% to 90.4p, though the company claimed a 7% rise to 118.3p for adjusted EPS. Like-for-like revenue at the time was up 6%, excluding RBP, with adjusted operating profit up 2% (though statutory operating profit fell 17%).

Looking at the spread of analysts’ opinions in the light of the year so far, I think Reckitt Benckiser’s 2013 EPS could be anywhere in a range of a few percent down to a few percent up.

Dividends

But what about dividends? Reckitt Benckiser traditionally provides a fairly average annual yield of a little over 3%, though it did rise a bit above that in the past couple of years as the share price fell back a little.

There’s a modest 3% rise in the 2013 dividend expected, to take it to about 138p per share for a yield of 3%. But the first-half dividend was lifted by 7% to 60p per share, so if anything that could be a bit conservative — in fact, the most recent forecasts are suggesting around 140p per share.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Alan does not own any shares in Reckitt Benckiser.

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »